Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent
Abdul Basit, Tanveer Ali, Shafiq ur Rehman
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 10, pp. 3605-3614
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 12, pp. 4362-4374
Open Access | Times Cited: 273
Peptide and peptide-based inhibitors of SARS-CoV-2 entry
Desirée Schütz, Yasser B. Ruiz‐Blanco, Jan Münch, et al.
Advanced Drug Delivery Reviews (2020) Vol. 167, pp. 47-65
Open Access | Times Cited: 170
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Yan Ling Ng, Cyrill Kafi Salim, Justin Jang Hann Chu
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107930-107930
Open Access | Times Cited: 132
Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
Sabyasachi Senapati, Pratibha Banerjee, Sandilya Bhagavatula, et al.
Journal of Genetics (2021) Vol. 100, Iss. 1
Open Access | Times Cited: 115
Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms
Mark Tristan J. Quimque, Kin Israel Notarte, Rey Arturo T. Fernandez, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 12, pp. 4316-4333
Open Access | Times Cited: 124
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
Sairaj Satarker, Tejas Ahuja, Madhuparna Banerjee, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 5, pp. 203-211
Open Access | Times Cited: 105
Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
Hongpeng Jia, Enid Neptune, Honggang Cui
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 64, Iss. 4, pp. 416-425
Open Access | Times Cited: 86
Drug targets for COVID-19 therapeutics: Ongoing global efforts
Ambrish Saxena
Journal of Biosciences (2020) Vol. 45, Iss. 1
Open Access | Times Cited: 80
Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2
Hadjer Khelfaoui, Dalal Harkati, Basil A. Saleh
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 18, pp. 7246-7262
Open Access | Times Cited: 78
Natural compounds fromClerodendrumspp. as possible therapeutic candidates against SARS-CoV-2: Anin silicoinvestigation
Pallab Kar, Neeta Raj Sharma, Bhupender Singh, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 13, pp. 4774-4785
Open Access | Times Cited: 76
Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation
Durgesh Kumar, Kamlesh Kumari, Vijay Kumar Vishvakarma, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 13, pp. 4671-4685
Open Access | Times Cited: 70
Potential detrimental role of soluble ACE2 in severe COVID‐19 comorbid patients
Mahmudur Rahman, Maruf Hasan, Asif Ahmed
Reviews in Medical Virology (2021) Vol. 31, Iss. 5, pp. 1-12
Open Access | Times Cited: 67
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature
Marissa LoPresti, David B. Beck, Priya Duggal, et al.
The American Journal of Human Genetics (2020) Vol. 107, Iss. 3, pp. 381-402
Open Access | Times Cited: 59
Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)
Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne V N, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 15, pp. 5735-5755
Open Access | Times Cited: 53
Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2
Rohitash Yadav, Mohammed Imran, Puneet Dhamija, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 12, pp. 4433-4448
Open Access | Times Cited: 52
Evaluation of Annona muricata Acetogenins as Potential Anti-SARS-CoV-2 Agents Through Computational Approaches
Shashanka K. Prasad, Sushma Pradeep, Chandan Shimavallu, et al.
Frontiers in Chemistry (2021) Vol. 8
Open Access | Times Cited: 44
Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain
Zachariah P. Schuurs, Edward Hammond, Stefano Elli, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2806-2818
Open Access | Times Cited: 41
Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach
Esraa Ismail, Shaza W. Shantier, Mona S. Mohammed, et al.
Journal of Chemistry (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 33
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15
Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2
Arif Jamal Siddiqui, Sadaf Jahan, Syed Amir Ashraf, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 17, pp. 6828-6841
Open Access | Times Cited: 33
Coiled-coil heterodimers with increased stability for cellular regulation and sensing SARS-CoV-2 spike protein-mediated cell fusion
Tjaša Plaper, Jana Aupič, Petra Dekleva, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
SARS-CoV-2 cell entry and targeted antiviral development
Zinuo Chen, Ruikun Du, Jazmin Galván Achi, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 12, pp. 3879-3888
Open Access | Times Cited: 27
Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
Tanzina Sharmin Nipun, Tanzila Ismail Ema, Md. Abdur Rashid Mia, et al.
Journal of Advanced Veterinary and Animal Research (2021) Vol. 8, Iss. 4, pp. 1-1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top